Bexarotene: Progression of extracutaneous lymphoma in patients with cutaneous lymphoma: 6 case reports

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1067, 2005-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bexarotene/interferon-α-2b: Extracutaneous tumour mass in a patient with primary cutaneous anaplastic large cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1111, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Bexarotene in combination with PUVA may be a treatment option in patients with cutaneous T-cell lymphoma refractory to multiple single-agent therapies

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Efalizumab: Progression of cutaneous T-cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Bexarotene: Fatal Hodgkin's lymphoma?: case report

Reactions Weekly, Vol. 1, Iss. 1320, 2010-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

Alemtuzumab/fludarabine: EBV-associated B-cell lymphoma in patients with peripheral T-cell lymphoma: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite